Ledipasvir/sofosbuvir for 8 weeks to treat acute hepatitis C virus infections in men with human immunodeficiency virus infections: sofosbuvir-containing regimens without interferon for treatment of acute HCV in HIV-1 infected individuals

Naggie S, Fierer DS, Hughes MD, et al. Ledipasvir/sofosbuvir for 8 weeks to treat acute hepatitis C virus infections in men with human immunodeficiency virus infections: sofosbuvir-containing regimens without interferon for treatment of acute HCV in HIV-1 infected individuals. Clin Infect Dis. 2019;69(3):514-522.

Publication Type:

Journal Article

Authors:

Naggie, S; Fierer, DS; Hughes, MD; et, al

Source:

Clin Infect Dis, Volume 69, Issue 3, p.514-522 (2019)

Cited On:

Export Citation:
RIS Format
Top